今开:0.0 | 昨收:11.83 |
最高:0.0 | 最低:0.0 |
涨停价:0.0 | 跌停价:0.0 |
总市值:6.21202587E8 |
chuminhua2023-01-31 12:19
1月30日,FDA 宣布批准 Stemline Therapeutics $Stemline医疗(STML)$ 的 口服选择性雌激素受体降解剂(SERD)Orserdu(elacestrant)用于患有 ER+/HER2-、ESR1 突变的晚期或转移性乳腺癌且在至少一种内分泌治疗后疾病进展的绝经后女性或成年男性。 该机构去年给与该申请优先审评。网页链接查看全文
Stemline医疗(STML)2020-02-15 10:35
$Stemline医疗(STML)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-022139 Size: 7 KB 网页链接查看全文
Stemline医疗(STML)2020-03-14 09:40
$Stemline医疗(STML)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-033491 Size: 8 KB 网页链接查看全文
Stemline医疗(STML)2020-02-15 10:35
$Stemline医疗(STML)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-022138 Size: 4 KB 网页链接查看全文
Stemline医疗(STML)2020-03-14 19:45
$Stemline医疗(STML)$ 内部交易: 2020-03-09,Chief Commercial Officer,Francomano Robert ,卖出,1266普通股, $5.00查看全文
Stemline医疗(STML)2020-02-13 02:05
$Stemline医疗(STML)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001145443-20-000103 Act: 34 Size: 107 KB 网页链接查看全文
Stemline医疗(STML)2020-02-29 10:40
$Stemline医疗(STML)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-027397 Size: 5 KB 网页链接查看全文
Stemline医疗(STML)2020-03-14 19:45
$Stemline医疗(STML)$ 内部交易: 2020-03-09,CEO,Bergstein Ivan ,卖出,20909普通股, $5.09查看全文
Stemline医疗(STML)2020-03-17 05:10
$Stemline医疗(STML)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001104659-20-034154 Act: 34 Size: 9 MB 网页链接查看全文
chuminhua2023-01-31 12:19
1月30日,FDA 宣布批准 Stemline Therapeutics $Stemline医疗(STML)$ 的 口服选择性雌激素受体降解剂(SERD)Orserdu(elacestrant)用于患有 ER+/HER2-、ESR1 突变的晚期或转移性乳腺癌且在至少一种内分泌治疗后疾病进展的绝经后女性或成年男性。 该机构去年给与该申请优先审评。网页链接查看全文
牛唐2020-01-16 21:55
研发类药企商业化任重道远,成功概率小,多半是好药在手,难以销售$Portola制药(PTLA)$ $Stemline医疗(STML)$ 就是这个道理。$欢聚时代(YY)$查看全文
$Stemline Therapeutics, Inc.(STML)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-09 AccNo: 0000215457-18-005334 Size: 12 KB 网页链接
$Stemline Therapeutics, Inc.(STML)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-09 AccNo: 0000215457-18-005334 Size: 12 KB 网页链接
$Stemline Therapeutics, Inc.(STML)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-09 AccNo: 0000315066-18-000963 Size: 9 KB 网页链接
$Stemline Therapeutics, Inc.(STML)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-09 AccNo: 0000215457-18-005334 Size: 12 KB 网页链接
$Stemline Therapeutics, Inc.(STML)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-09 AccNo: 0000215457-18-005334 Size: 12 KB 网页链接
$Stemline Therapeutics, Inc.(STML)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-07 AccNo: 0000038777-18-000120 Size: 195 KB 网页链接
$Stemline Therapeutics, Inc.(STML)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-07 AccNo: 0000038777-18-000120 Size: 195 KB 网页链接
$Stemline Therapeutics, Inc.(STML)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2018-02-01 AccNo: 0000215457-18-004654 Size: 13 KB 网页链接
$Stemline Therapeutics, Inc.(STML)$ 8-K - Current report Filed: 2018-01-24 AccNo: 0001104659-18-003778 Size: 664 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Stemline Therapeutics, Inc.(STML)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2018-01-24 AccNo: 0001047469-18-000389 Size: 412 KB 网页链接